451 related articles for article (PubMed ID: 38003309)
1. From Recognition to Remedy: The Significance of Biomarkers in Neurodegenerative Disease Pathology.
Toader C; Dobrin N; Brehar FM; Popa C; Covache-Busuioc RA; Glavan LA; Costin HP; Bratu BG; Corlatescu AD; Popa AA; Ciurea AV
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003309
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers for Managing Neurodegenerative Diseases.
Cheslow L; Snook AE; Waldman SA
Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672416
[TBL] [Abstract][Full Text] [Related]
3. Sex and gender differences in Alzheimer's disease, Parkinson's disease, and Amyotrophic Lateral Sclerosis: A narrative review.
Nicoletti A; Baschi R; Cicero CE; Iacono S; Re VL; Luca A; Schirò G; Monastero R;
Mech Ageing Dev; 2023 Jun; 212():111821. PubMed ID: 37127082
[TBL] [Abstract][Full Text] [Related]
4. Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment.
Pathak N; Vimal SK; Tandon I; Agrawal L; Hongyi C; Bhattacharyya S
Metab Brain Dis; 2022 Jan; 37(1):67-104. PubMed ID: 34719771
[TBL] [Abstract][Full Text] [Related]
5. Machine Learning and Digital Biomarkers Can Detect Early Stages of Neurodegenerative Diseases.
Chudzik A; Śledzianowski A; Przybyszewski AW
Sensors (Basel); 2024 Feb; 24(5):. PubMed ID: 38475108
[TBL] [Abstract][Full Text] [Related]
6. Molecular Biomarkers and Their Implications for the Early Diagnosis of Selected Neurodegenerative Diseases.
Doroszkiewicz J; Groblewska M; Mroczko B
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563001
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers in Neurodegenerative Diseases.
Jeromin A; Bowser R
Adv Neurobiol; 2017; 15():491-528. PubMed ID: 28674995
[TBL] [Abstract][Full Text] [Related]
8. Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases.
Sheinerman KS; Toledo JB; Tsivinsky VG; Irwin D; Grossman M; Weintraub D; Hurtig HI; Chen-Plotkin A; Wolk DA; McCluskey LF; Elman LB; Trojanowski JQ; Umansky SR
Alzheimers Res Ther; 2017 Nov; 9(1):89. PubMed ID: 29121998
[TBL] [Abstract][Full Text] [Related]
9. Omics Data and Their Integrative Analysis to Support Stratified Medicine in Neurodegenerative Diseases.
La Cognata V; Morello G; Cavallaro S
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34062930
[TBL] [Abstract][Full Text] [Related]
10. Human salivary Raman fingerprint as biomarker for the diagnosis of Amyotrophic Lateral Sclerosis.
Carlomagno C; Banfi PI; Gualerzi A; Picciolini S; Volpato E; Meloni M; Lax A; Colombo E; Ticozzi N; Verde F; Silani V; Bedoni M
Sci Rep; 2020 Jun; 10(1):10175. PubMed ID: 32576912
[TBL] [Abstract][Full Text] [Related]
11. Blood-Based Transcriptomic Biomarkers Are Predictive of Neurodegeneration Rather Than Alzheimer's Disease.
Shvetcov A; Thomson S; Spathos J; Cho AN; Wilkins HM; Andrews SJ; Delerue F; Couttas TA; Issar JK; Isik F; Kaur S; Drummond E; Dobson-Stone C; Duffy SL; Rogers NM; Catchpoole D; Gold WA; Swerdlow RH; Brown DA; Finney CA
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834458
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers of neurodegenerative disorders: how good are they?
Rachakonda V; Pan TH; LE WD
Cell Res; 2004 Oct; 14(5):347-58. PubMed ID: 15538967
[TBL] [Abstract][Full Text] [Related]
13. Physical Exercise-Induced Myokines in Neurodegenerative Diseases.
Lee B; Shin M; Park Y; Won SY; Cho KS
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071457
[TBL] [Abstract][Full Text] [Related]
14. Metabolic Biomarkers and Neurodegeneration: A Pathway Enrichment Analysis of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.
Kori M; Aydın B; Unal S; Arga KY; Kazan D
OMICS; 2016 Nov; 20(11):645-661. PubMed ID: 27828769
[TBL] [Abstract][Full Text] [Related]
15. [The role of steroid hormones in the neurodegenerative diseases].
Sadowska A; Grzesiak M
Postepy Biochem; 2022 Dec; 68(4):387-398. PubMed ID: 36649137
[TBL] [Abstract][Full Text] [Related]
16. Morphometric and Nanomechanical Screening of Peripheral Blood Cells with Atomic Force Microscopy for Label-Free Assessment of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.
Taneva SG; Todinova S; Andreeva T
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762599
[TBL] [Abstract][Full Text] [Related]
17. Panoramic Visualization of Circulating MicroRNAs Across Neurodegenerative Diseases in Humans.
Brennan S; Keon M; Liu B; Su Z; Saksena NK
Mol Neurobiol; 2019 Nov; 56(11):7380-7407. PubMed ID: 31037649
[TBL] [Abstract][Full Text] [Related]
18. The Microbiome as a Modifier of Neurodegenerative Disease Risk.
Fang P; Kazmi SA; Jameson KG; Hsiao EY
Cell Host Microbe; 2020 Aug; 28(2):201-222. PubMed ID: 32791113
[TBL] [Abstract][Full Text] [Related]
19. The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders.
Olesen MA; Villavicencio-Tejo F; Quintanilla RA
Transl Neurodegener; 2022 Jul; 11(1):36. PubMed ID: 35787292
[TBL] [Abstract][Full Text] [Related]
20. Sirtuins and Their Implications in Neurodegenerative Diseases from a Drug Discovery Perspective.
Yeong KY; Berdigaliyev N; Chang Y
ACS Chem Neurosci; 2020 Dec; 11(24):4073-4091. PubMed ID: 33280374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]